Coronary heart disease
Conditions
Interventions
Test group:Xuesaitong soft capsule + basic treatment
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: follow the diagnostic criteria, aged 35-70 years old, and sign the informed consent
Exclusion criteria
Exclusion criteria: Stable angina;acute myocardial infarction; chest pain caused by congenital heart disease, valvular disease and severe neurosis; NYHA classification of cardiac function is III or IV; chest pain caused by arrhythmia; acute cerebral infarction; combined liver, kidney and blood system primary serious diseases; recent acute infection within 2 weeks; with other serious diseases and must be treated (such as cancer); uncontrolled diabetes, or with serious diabetic complications; mental disordered that could not complete questionnaires; pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lncRNA;miRNA;mRNA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Seattle Angina Questionnaiire;Questionnaire of coronary heart disease with blood stasis syndrome;Safety evaluation:incidence of adverse events,vital signs, ECG, myocardial enzymes, coagulation, blood lipids and other laboratory values; | — |
Countries
China
Contacts
Public ContactJie Wang
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed